BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37958668)

  • 1. Comparison and Validation of Rapid Molecular Testing Methods for Theranostic Epidermal Growth Factor Receptor Alterations in Lung Cancer: Idylla versus Digital Droplet PCR.
    Léonce C; Guerriau C; Chalabreysse L; Duruisseaux M; Couraud S; Brevet M; Bringuier PP; Poncet DA
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced sensitivity for
    Lee E; Jones V; Topkas E; Harraway J
    J Clin Pathol; 2021 Jan; 74(1):43-47. PubMed ID: 32467321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of epidermal growth factor receptor mutation detection turnaround times and concordance among real-time polymerase chain reaction, high-throughput next-generation sequencing and the Biocartis Idylla™ platforms in non-small cell lung carcinomas.
    Sharma S; Satapathy A; Aggarwal A; Dewan A; Jain E; Katara R; Kumar V; Pal R; Pandey S; Naidu MM; Kini L; Pradhan D; Mohanty SK
    Pathol Res Pract; 2021 Apr; 220():153394. PubMed ID: 33706124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical Droplet Digital Polymerase Chain Reaction Patterns That Indicate Uncommon but Clinically Actionable EGFR Mutations in Lung Cancer.
    Lechner A; Rai A; Rojas-Rudilla V; Kuang Y; Paweletz CP; Sholl LM; Dong F
    Arch Pathol Lab Med; 2024 May; 148(5):553-558. PubMed ID: 37639432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comparison of ddPCR and ARMS for detecting EGFR T790M status in ctDNA from advanced NSCLC patients with acquired EGFR-TKI resistance.
    Wang W; Song Z; Zhang Y
    Cancer Med; 2017 Jan; 6(1):154-162. PubMed ID: 28000387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of epidermal growth factor receptor (EGFR) gene T790M mutation by droplet digital PCR and Super-ARMS PCR in plasma ctDNA samples of non-small cell lung cancer patients with the resistance to EGFR-tyrosine kinase inhibitor].
    Cao ZY; Wu W; Hou LK; Zhang W; Gao CX; Wu CY; Zhang LP
    Zhonghua Bing Li Xue Za Zhi; 2018 Dec; 47(12):910-914. PubMed ID: 30522170
    [No Abstract]   [Full Text] [Related]  

  • 7. Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung Cancer.
    Sacher AG; Paweletz C; Dahlberg SE; Alden RS; O'Connell A; Feeney N; Mach SL; Jänne PA; Oxnard GR
    JAMA Oncol; 2016 Aug; 2(8):1014-22. PubMed ID: 27055085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idylla
    Khalifa E; Chapusot C; Tournier B; Sentis J; Marion E; Remond A; Aubry M; Pioche C; Bergeron A; Primois C; Blanchard L; Millière A; Boucheix M; Léger Y; Bairrao M; Brouste V; Martin L; Soubeyran I
    J Clin Pathol; 2023 Oct; 76(10):698-704. PubMed ID: 35820776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance evaluation of the Biocartis Idylla EGFR Mutation Test using pre-extracted DNA from a cohort of highly characterised mutation positive samples.
    Grant J; Stanley A; Balbi K; Gerrard G; Bennett P
    J Clin Pathol; 2022 Apr; 75(4):241-249. PubMed ID: 33514586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid and reliable testing for clinically actionable EGFR mutations in non-small cell lung cancer using the Idylla
    Michaelidou K; Karniadakis I; Pantelaion V; Koutoulaki C; Boukla E; Folinas K; Dimaras P; Papadaki MA; Koutsopoulos AV; Mavroudis D; Vourlakou C; Mavridis K; Agelaki S
    Expert Rev Mol Diagn; 2024; 24(1-2):89-98. PubMed ID: 38193169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of EGFR mutations in non-small cell lung cancer by droplet digital PCR.
    Williamson DFK; Marris SRN; Rojas-Rudilla V; Bruce JL; Paweletz CP; Oxnard GR; Sholl LM; Dong F
    PLoS One; 2022; 17(2):e0264201. PubMed ID: 35202431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of epidermal growth factor receptor gene mutations in different types of non-small cell lung cancer by droplet digital PCR and amplification refractory mutation system].
    Li R; Ye SB; He Y; Wang X; Wu N; Xia QY; Shen Q; Shi SS
    Zhonghua Bing Li Xue Za Zhi; 2017 Nov; 46(11):764-768. PubMed ID: 29136689
    [No Abstract]   [Full Text] [Related]  

  • 13. Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Formalin-Fixed, Paraffin-Embedded Tissue of Human Lung Cancer.
    Evrard SM; Taranchon-Clermont E; Rouquette I; Murray S; Dintner S; Nam-Apostolopoulos YC; Bellosillo B; Varela-Rodriguez M; Nadal E; Wiedorn KH; Melchior L; Andrew E; Jones M; Ridgway J; Frykman C; Lind L; Rot M; Kern I; Speel EJM; Roemen GMJM; Trincheri N; Freiberger SN; Rechsteiner M
    J Mol Diagn; 2019 Nov; 21(6):1010-1024. PubMed ID: 31445213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a fast and fully automated platform to diagnose
    Lambros L; Caumont C; Guibourg B; Barel F; Quintin-Roué I; Marcorelles P; Merlio JP; Uguen A
    J Clin Pathol; 2017 Jun; 70(6):544-549. PubMed ID: 28153953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR Mutations in Cell-free Plasma DNA from Patients with Advanced Lung Adenocarcinoma: Improved Detection by Droplet Digital PCR.
    Buder A; Setinek U; Hochmair MJ; Schwab S; Kirchbacher K; Keck A; Burghuber OC; Pirker R; Filipits M
    Target Oncol; 2019 Apr; 14(2):197-203. PubMed ID: 30810887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment and validation of a novel droplet digital PCR assay for ultrasensitive detection and dynamic monitoring of EGFR mutations in peripheral blood samples of non-small-cell lung cancer patients.
    Tang C; Zhu L; Zhang L; Tan C; Peng Z; Liu B; Liu W; Hu H; Bai Y; Wang B; Lin L; Liang J; Li X; Guo Y; Liu Y
    Clin Chim Acta; 2020 Nov; 510():88-96. PubMed ID: 32645388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing Ultrasensitive Library-Aliquot-Based Droplet Digital PCR for Detecting T790M in Plasma-Circulating Tumor DNA of Non-small-Cell-Lung-Cancer Patients.
    Yang K; Li J; Zhao J; Ren P; Wang Z; Wei B; Dong B; Sun R; Wang X; Groen HJM; Ma J; Guo Y
    Anal Chem; 2018 Oct; 90(19):11203-11209. PubMed ID: 30156405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compared to plasma, bronchial washing fluid shows higher diagnostic yields for detecting EGFR-TKI sensitizing mutations by ddPCR in lung cancer.
    Lee SH; Kim EY; Kim T; Chang YS
    Respir Res; 2020 Jun; 21(1):142. PubMed ID: 32517757
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    De Luca C; Gragnano G; Pisapia P; Vigliar E; Malapelle U; Bellevicine C; Troncone G
    J Clin Pathol; 2017 Apr; 70(4):295-300. PubMed ID: 27543600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced non-small cell lung cancer: Rapid evaluation of EGFR status on fine-needle cytology samples using Idylla.
    D'Ardia A; Caputo A; Fumo R; Ciaparrone C; Gaeta S; Picariello C; Zeppa P; D'Antonio A
    Pathol Res Pract; 2021 Aug; 224():153547. PubMed ID: 34280752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.